Vaccine Design, Development, and Delivery
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
This Section aims to highlight the latest advances in the design and development of both traditional and next-generation vaccines, which hold promise for providing solutions to challenging targets for which conventional approaches have proven ineffective. We strive to discuss emerging approaches to vaccine design and engineering based on recent insights into immunology, immune engineering, and novel immunological mechanisms, as well as translational applications and the development of next-generation therapeutic vaccines.
Scope
The Section welcomes high-quality papers that explore the design, development, and delivery of attenuated, inactivated, live, subunit, and vectored vaccines, the use of adjuvants in any formulation, and mechanisms involved in the immune responses. Advancements in the field are poised to enhance the efficacy and safety of vaccines, as well as to develop non-invasive delivery mechanisms. We encourage you to submit an original research paper or review article for peer review.
Keywords
- vaccine design
- traditional vaccine
- next-generation vaccine
- therapeutic vaccine
- non-invasive delivery
- mucosal and systemic vaccine
- adjuvants
- immunity
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Strategies of Viral Vectors for Vaccine Development (Deadline: 31 August 2025)
- Virus-Like Particle (VLP) Vaccines Against Emerging Infectious Diseases—2nd Edition (Deadline: 30 September 2025)
- Nanomaterial Application in Vaccines (Deadline: 31 October 2025)
- Research in Vaccine Adjuvants: Innovations and Challenges (Deadline: 31 October 2025)
- Viral Vector-Based Vaccines and Therapeutics (Deadline: 31 October 2025)
- Bioengineering in Vaccine Design and Delivery (Deadline: 1 November 2025)
- Advances in the Use of Nanoparticles for Vaccine Platform Development: 2nd Edition (Deadline: 30 November 2025)
- Recent Advances in Virus-Like Particle-Based Vaccines (Deadline: 31 December 2025)
- Advances in Vaccine Adjuvants (Deadline: 31 January 2026)
- Innovations in Vaccine Technology (Deadline: 31 January 2026)
- Vaccine Design and Development (Deadline: 31 January 2026)
- Virus-Like Particle Vaccine Development (Deadline: 31 January 2026)
- Nanoparticle-Based Delivery Systems for Vaccines (Deadline: 28 February 2026)
- Applications of Nanoparticles in Vaccines (Deadline: 28 February 2026)
- Mucosal Vaccines: Advances in Technology and Delivery (Deadline: 28 February 2026)
- Novel Adjuvants and Delivery Systems for Vaccines (Deadline: 31 March 2026)
- Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity (Deadline: 30 April 2026)
- Advances in Plant Genetic Engineered Vaccines (Deadline: 30 April 2026)
- Novel Adjuvants and Delivery Technologies for Vaccine Development (Deadline: 31 May 2026)
- Recent Research on Adenovirus-Vectored Vaccines (Deadline: 31 May 2026)
- State-of-the-Art Vaccine Design (Deadline: 30 June 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
